Results 201 to 210 of about 835,413 (266)

Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis. [PDF]

BMC Gastroenterol
Mahmoud MS, Mshaly MS, Abdel-Reheim HN, Shawki MM, Meshref RA, Mohamed EI.   +5 more
europepmc   +1 more source

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease

Hepatology Research, Volume 56, Issue 10, Page 1466-1474, October 2026.
ABSTRACT Aim Steatotic liver disease (SLD) encompasses a heterogeneous spectrum with varying risks of hepatocellular carcinoma (HCC). Limited sample sizes limit the development of predictive models, particularly for rare outcomes. This study evaluated whether generative artificial intelligence (AI)‐based synthetic data augmentation can enhance HCC risk
Masaya Sato, Takuma Nakatsuka, Yuki Matsushita, Takuma Kaneko, Keisuke Mabuchi, Tomoharu Yamada, Kazuya Okushin, Tatsuya Minami, Yotaro Kudo, Satoshi Kodera, Kazuhiko Koike, Mitsuhiro Fujishiro, Ryosuke Tateishi   +12 more
wiley   +1 more source

Comparative analysis of the predictive value of the ASAP model and the GAAD model for liver cancer high risk cohorts. [PDF]

Sci Rep
Zhang L, Xie C, Huang Y, Jiang D.
europepmc   +1 more source

Gaps in the Cascade of Care Contribute to Poor Liver Cancer Outcomes Among People Living With Hepatitis B: A Multicenter Observational Cohort Study

Journal of Gastroenterology and Hepatology, Volume 41, Issue 10, Page 3128-3139, October 2026.
ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa, Joan Ericka Flores, Michael Macisaac, Jack Wallace, Joseph Doyle, Marno Ryan, Thai Hong, Brett Knowles, Adrian Fox, Ashu Jhamb, Tom Sutherland, Stuart Roberts, William Kemp, Ammar Majeed, Marie Sinclair, Rohit Sawhney, Stephen Bloom, Amanda Nicoll, Zina Valaydon, Gauri Mishra, Sid Sood, Diana Lewis, A. Thompson, J. Howell   +23 more
wiley   +1 more source

Protein Induced by Vitamin K Absence or Antagonist-II: Significantly Elevated in Obstructive Jaundice and Sepsis Patients Without Hepatocellular Carcinoma. [PDF]

J Clin Lab Anal
Zhang K, Ye X, Fu X.
europepmc   +1 more source

Impact of PD‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy

Liver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background and Aims The optimal sequencing of programmed cell death protein 1 (PD‐1) inhibitors relative to locoregional therapy (LRT) in unresectable hepatocellular carcinoma (uHCC) remains undefined. This study evaluated the impact of PD‐1 inhibitor timing on outcomes in patients receiving hepatic arterial infusion chemotherapy (HAIC) or ...
Jian He, Jian Chen, Bohua Yu, Fuqun Wei, Weifu Liu, Peishu Huang, Songhui Wu, Xiang You, Zhisheng Chen, Ziqi Lin, Wuhua Guo, Shaowu Zhuang, Yiping Chen, Zhongwu Chen   +13 more
wiley   +1 more source

Optimizing early screening for hepatocellular carcinoma: Diagnostic value of ultrasonography combined with serum biomarkers. [PDF]

Medicine (Baltimore)
Yan S.
europepmc   +1 more source

Prognostic Value of Liver Stiffness in Advanced Chronic Liver Disease After Hepatitis C Virus Eradication

Liver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background & Aim Sustained‐virological‐response (SVR) after direct‐acting‐antiviral (DAA) therapy improves outcomes in patients with HCV‐related compensated‐advanced‐chronic‐liver‐disease (cACLD). However, it remains unclear whether absolute post‐SVR LSM or LSM reduction better predicts prognosis after SVR.
Federica Cerini, Mariagrazia Rumi, Jonas Schropp, Agostino Cosenza, Carmelo Selvaggio, Chiara Masellis, Annalisa Berzigotti   +6 more
wiley   +1 more source

Development and validation of a clinical-adipometric nomogram for predicting tumor response to transarterial chemoembolization in hepatocellular carcinoma. [PDF]

Sci Rep
Zhao J, Fu G, Wang Y, Yang H.
europepmc   +1 more source

Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug‐Induced Liver Injury

Liver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background & Aims Drug‐induced liver injury (DILI) would progress to chronicity or death. Large language models (LLMs) may enhance clinical decision‐making, yet their utility relative to physicians in DILI remains unclear. Therefore, we evaluated their performance in predicting DILI outcomes.
Haoshuang Fu, Yanan Du, Gangde Zhao, Yuelin Xiao, Shuying Song, Xinya Zang, Tianhui Zhou, Yan Zhuang, Ruidong Mo, Rongtao Lai, Qing Xie   +10 more
wiley   +1 more source